Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Pharmaceutical Design|May 14, 2008
Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoaKaren M GrantPakistan Journal of Biological Sciences : PJBS|August 20, 2011
Molecular cloning, characterization and overexpression of a novel cyclin from Leishmania mexicanaNahla O M Ali, Muntaser E Ibrahim, Karen M Grant, et al.Parasites & Vectors|July 17, 2009
Malaria ookinetes exhibit multiple markers for apoptosis-like programmed cell death in vitroShashini C Arambage, Karen M Grant, Ian Pardo, et al.The Journal of Biological Chemistry|April 20, 2002
Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitorMarie Knockaert, Karen Wieking, Sophie Schmitt, et al.Molecular and Biochemical Parasitology|March 27, 2010
Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178Felipe C Gomes, Nahla Osman M Ali, Elaine Brown, et al.International Journal for Parasitology|May 19, 2009
6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasisEvangelia Xingi, Despina Smirlis, Vassilios Myrianthopoulos, et al.Antimicrobial Agents and Chemotherapy|July 27, 2004
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activityKaren M Grant, Morag H Dunion, Vanessa Yardley, et al.Plos Neglected Tropical Diseases|April 13, 2011
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinaseRoderick G Walker, Graeme Thomson, Kirk Malone, et al.Pageof 1